finance.yahoo.comLexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights9 months ago
benzinga.comWhy SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session9 months ago
finance.yahoo.comCompanies Like Lexeo Therapeutics (NASDAQ:LXEO) Are In A Position To Invest In Growth11 months ago
finance.yahoo.comLexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathyabout 1 year ago
finance.yahoo.comLexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathyabout 1 year ago
finance.yahoo.comLexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financingabout 1 year ago
finance.yahoo.comLexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointmentsabout 1 year ago
finance.yahoo.comLexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conferenceover 1 year ago